Literature DB >> 23436467

Cutaneous dyspigmentation in patients with ganglioside GM3 synthase deficiency.

Heng Wang1, Alicia Bright, Baozhong Xin, J R Bockoven, Amy S Paller.   

Abstract

Ganglioside GM3 synthase deficiency is a rare autosomal recessive metabolic disorder characterized by infantile onset of severe irritability and epilepsy, failure to thrive, developmental stagnation, and cortical blindness. Because of the lack of easily recognizable dysmorphism and specific neurologic manifestations, identification of patients with this condition is extremely challenging. Here we report on previously undescribed pigmentary abnormalities in 20 of 38 patients with GM3 synthase deficiency. All 20 of the patients showed freckle-like hyperpigmented macules, ranging in size from 2 to 5 mm in diameter and usually found bilaterally on the extremities, especially the dorsal aspects of the hands and feet. Seven of these patients also had depigmented macules and patches, especially on the face and extremities. These cutaneous changes were asymptomatic, and were not associated with the severity or particular phenotype of the neurologic disease. They became visible only after the first years of life with an increased incidence with advancing age. These distinct pigmentary features are not identified in 54 normal siblings, and may provide a useful clue in identifying patients with ganglioside metabolic disorders.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23436467     DOI: 10.1002/ajmg.a.35826

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  17 in total

1.  A mutation in a ganglioside biosynthetic enzyme, ST3GAL5, results in salt & pepper syndrome, a neurocutaneous disorder with altered glycolipid and glycoprotein glycosylation.

Authors:  Luigi Boccuto; Kazuhiro Aoki; Heather Flanagan-Steet; Chin-Fu Chen; Xiang Fan; Frank Bartel; Marharyta Petukh; Ayla Pittman; Robert Saul; Alka Chaubey; Emil Alexov; Michael Tiemeyer; Richard Steet; Charles E Schwartz
Journal:  Hum Mol Genet       Date:  2013-09-10       Impact factor: 6.150

2.  Sialylation regulates brain structure and function.

Authors:  Seung-Wan Yoo; Mary G Motari; Keiichiro Susuki; Jillian Prendergast; Andrea Mountney; Andres Hurtado; Ronald L Schnaar
Journal:  FASEB J       Date:  2015-04-06       Impact factor: 5.191

3.  ST3GAL5-Related Disorders: A Deficiency in Ganglioside Metabolism and a Genetic Cause of Intellectual Disability and Choreoathetosis.

Authors:  Eliza Gordon-Lipkin; Julie S Cohen; Siddharth Srivastava; Bruno P Soares; Eric Levey; Ali Fatemi
Journal:  J Child Neurol       Date:  2018-09-05       Impact factor: 1.987

Review 4.  Human genetic disorders of sphingolipid biosynthesis.

Authors:  Leonardo Astudillo; Frédérique Sabourdy; Nicole Therville; Heiko Bode; Bruno Ségui; Nathalie Andrieu-Abadie; Thorsten Hornemann; Thierry Levade
Journal:  J Inherit Metab Dis       Date:  2014-08-21       Impact factor: 4.982

5.  Ganglioside GM3 Mediates Glucose-Induced Suppression of IGF-1 Receptor-Rac1 Activation to Inhibit Keratinocyte Motility.

Authors:  Duncan Hieu M Dam; Xiao-Qi Wang; Sarah Sheu; Mahima Vijay; Desmond Shipp; Luke Miller; Amy S Paller
Journal:  J Invest Dermatol       Date:  2016-10-08       Impact factor: 8.551

6.  Ganglioside GM3 is essential for the structural integrity and function of cochlear hair cells.

Authors:  Misato Yoshikawa; Shinji Go; Shun-ichi Suzuki; Akemi Suzuki; Yukio Katori; Thierry Morlet; Steven M Gottlieb; Michihiro Fujiwara; Katsunori Iwasaki; Kevin A Strauss; Jin-ichi Inokuchi
Journal:  Hum Mol Genet       Date:  2015-02-04       Impact factor: 6.150

7.  Mass spectrometric quantification of plasma glycosphingolipids in human GM3 ganglioside deficiency.

Authors:  Kazuhiro Aoki; Adam D Heaps; Kevin A Strauss; Michael Tiemeyer
Journal:  Clin Mass Spectrom       Date:  2019-03-16

Review 8.  Skin manifestations in CDG.

Authors:  D Rymen; J Jaeken
Journal:  J Inherit Metab Dis       Date:  2014-02-20       Impact factor: 4.982

Review 9.  Sialic acids in the brain: gangliosides and polysialic acid in nervous system development, stability, disease, and regeneration.

Authors:  Ronald L Schnaar; Rita Gerardy-Schahn; Herbert Hildebrandt
Journal:  Physiol Rev       Date:  2014-04       Impact factor: 37.312

10.  Oral Ganglioside Supplement Improves Growth and Development in Patients with Ganglioside GM3 Synthase Deficiency.

Authors:  Heng Wang; Valerie Sency; Paul McJarrow; Alicia Bright; Qianyang Huang; Karen Cechner; Julia Szekely; JoAnn Brace; Andi Wang; Danting Liu; Angela Rowan; Max Wiznitzer; Aimin Zhou; Baozhong Xin
Journal:  JIMD Rep       Date:  2018-09-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.